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Purpose: beyond the pure morphological visual representation, MR imaging oﬀers the possibility to quantify parameters in the
healthy, as well as, in pathologic lung parenchyma. Gas exchange is the primary function of the lung and the transport of oxygen
plays a key role in pulmonary physiology and pathophysiology. The purpose of this review is to present a short overview of the
relaxation mechanisms of the lung and the current technical concepts of T1 mapping and methods of oxygen enhanced MR
imaging. Material and Methods: molecular oxygen has weak paramagnetic properties so that an increase in oxygen concentration
results in shortening of the T1 relaxation time and thus to an increase of the signal intensity in T1 weighted images. A possible
way to gain deeper insights into the relaxation mechanisms of the lung is the calculation of parameter Maps. T1 Maps based
on a snapshot FLASH sequence obtained during the inhalation of various oxygen concentrations provide data for the creation
of the so-called oxygen transfer function (OTF), assigning a measurement for local oxygen transfer. T1 weighted single shot TSE
sequencesalsopermitexpressionofthesignalchangingeﬀectsassociatedwiththeinhalationofpureoxygen.Results:theaverageof
the mean T1 values over the entire lung in inspiration amounts to 1199 +/− 117 milliseconds, the average of the mean T1 values in
expiration was 1333 +/− 167 milliseconds. T1 Maps of patients with emphysema and lung ﬁbrosis show fundamentally diﬀerent
behavior patterns. Oxygen enhanced MRT is able to demonstrate reduced diﬀusion capacity and diminished oxygen transport
in patients with emphysema and cystic ﬁbrosis. Discussion: results published in literature indicate that T1 mapping and oxygen
enhanced MR imaging are promising new methods in functional imaging of the lung and when evaluated in conjunction with the
pure morphological images can provide additional valuable information.
Copyright © 2007 Alfred Stadler et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Beyond the pure morphological visual representation, MR
imaging oﬀers the possibility to quantify functional param-
eters in healthy, as well as, the pathologic lung tissue. The
T1 time of biological tissue is one of the potential measur-
able parameters. Gas exchange is the primary function of the
lung and oxygenuptakeplaysa major rolein lung physiology
and pathophysiology. Consequently, the representation and
quantiﬁcation of lung oxygen uptake provides important in-
formation regarding pulmonary function. Furthermore, im-
age creation of pathologically altered oxygen exchange in the
diseased lung is of great preclinical and clinical interest. Due
to the paramagnetic properties of oxygen, MR imaging of
oxygen transport is theoretically possible. The purpose of
this review is to present a short overview of the relaxation
mechanisms of the lung and the current technical concepts
of T1 mapping and methods of oxygen enhanced MR imag-
ing.
2. PULMONARY RELAXATION MECHANISMS
The ﬁrst order approximation of the lung T1 relaxation time
shows it to be monoexponential and considerably dependant
upon tissue water content: the greater the water content the
shorter the T1 time [1, 2]. In a majority of studies, alteration
of T1 relaxation times in pathologically-changed lungs (i.e.,
pulmonaryedema)couldbequalitativelyexplainedbytheef-
fect of water in the lungs [3], even though the measurements













Figure 1: T1 map of a healthy subject: expiration (b) demonstrates
a lengthening of the T1 times (seconds) as compared to inspiration
(a).
observed in animal experiments, or in ex vivo observations
of various pathologies (i.e., Lung ﬁbrosis) could not solely be
explained by the eﬀect of lung water [5–8].
The explanation of MR relaxation mechanisms in the
presence of macromolecules, such as collagen, was simpliﬁed
via the development of a theoretical model which is based
on the interaction between water molecules and macro-
molecules[9].ThistakesintoaccountthatthepulmonaryT1
relaxation properties are determined by two balanced groups
of water molecules: one compartment consists of free water
and the other by water which is bound to macromolecules
such as collagen. An alteration of the lung parenchyma, such
as the increase in the quantity of macromolecules, leads to a
change in the water-bound fraction and therefore a change
in the proportion of water-bound molecules.
A signiﬁcant percentage of signal generating protons are
found in the blood. Parenchymal regional perfusion will,
therefore, have an eﬀect on the regional lung parenchymal
T1 relaxation time. Lung perfusion and airspace oxygen con-
tent are dependent from the respiratory phase. However, in a
recent publication, we illustrated that the T1 time in inspira-
tion(1199+/−117milliseconds)isshorterthaninexpiration
(1333+ /−167 milliseconds) [10]( Figure 1).
3. OXYGEN AS CONTRAST MEDIUM
Due to two unpaired electrons, molecular oxygen has weak
paramagnetic properties with a magnetic moment of 2.8
Bohr magnetons. The idea to use oxygen as a paramagnetic
contrast medium is not new and was initially discussed by
Young et al. [11]. The potential advantages of oxygen as a
contrast medium are obvious. Oxygen is inexpensive, readily
available, and safe. Short-term inhalation is not associated
with any adverse side-eﬀects. Only after continuous inhala-
tion of 100% oxygen for more than 24 hours does the possi-
bility ofpermanentpathologicallung changesarise [12].The
illustration of oxygen dispersion is of great physiological and














Figure 2: T1 map (seconds) of a healthy subject with inhalation of
room air 21% oxygen (a), as well as inhalation of 100% oxygen (b).
The increase of O2 concentration shortens the T1 time of the lung
parenchyma as well as the Aorta (arrow).
sents the essential function of the lungs and not the distribu-
tion of nonphysiological substances which are measured in
examinations such as a nuclear medicine-pulmonary func-
tion test. A portion of oxygen is bound to hemoglobin in the
pulmonary capillary bed and a small fraction remains in sol-
ubleform.Thehemoglobinboundoxygenisenclosedwithin
the erythrocyte and therefore, the tissue water protons can-
not engage in a spin-lattice interaction which leads to T1 re-
laxation [13]. Edelman et al. were the ﬁrst to discuss the use
of the paramagnetic properties of soluble oxygen to illustrate
pulmonary oxygen transport [14]. Inhalation of pure oxygen
increases the PaO2 in the lungs. This increase in partial oxy-
gen pressure leads to a shortening of the T1 time (Figure 2)
and therefore, to a signal rise of the T1 weighted images
[15]. Animal studies demonstrated a linear correlation be-
tween PaO2 and lung parenchymal relaxivity (=1/T1) [16].
The diﬀerence in lung parenchymal acquisition signal inten-
sitiesbetweeninhaledroomairand100%oxygenisminimal,
and visual representation is generally accomplished by image
subtraction. Apart from the lungs, signal increases were also
noted in other organs such as the aorta, spleen, and kidneys
[15]. Besides the eﬀect on T1, an elevated oxygen concentra-
tion also leads to a prolongation of lung parenchymal T2∗
time with only a minimal inﬂuence on the signal intensity
[16].
The exact mechanism altering signal or the change in
T1 time is not known. The inﬂuence of oxygen on T1 time
seems to be played out on the pulmonary vein and parenchy-
m a ll e v e l s[ 17]. The molecular oxygen paramagnetic eﬀect
is in any case not measurable within the pulmonary gaseous
spaces in that the oxygen only inﬂuences relaxation of water
protons in its proximate surroundings and is itself not signal
emitting. After inhalation of higher oxygen concentrations,
theinterplayofinhalation,diﬀusion,andperfusioninﬂuence
theconventionalacquisitionsignalandalsoaltertheT1time.
It only follows that there is a measurable diﬀerences in signal
behavior in the pathological lung after inhalation of oxygen
which results from an alteration of one or more of these fac-




































Figure 3: T1 Measurements: after a 180◦ inversion pulse, 16 Images were acquired at speciﬁc time points using a snapshot FLASH sequence.
The individual measurements have a duration of 224 milliseconds, the complete slice 3,5 seconds. Due to the short acquisition time, patients
with moderate dyspnea can be examined using this method. An exponential function was assigned to each Pixel covering the time span of
the 16 measured signal intensities from which a Pixel T1 time can be calculated. The ﬁnal T1 map results from the color coding of the T1
values.
Ohno et al. [18] used the absolute sum of the signal rise
during a dynamic measurement as a parameter for lung dif-
fusion capacity, M¨ uller et al. [19] the slope of the rise.
Oxygen Transfer Function (OTF) was created to describe
the oxygen transport T1 maps [20]. This was achieved by
measuring T1 maps at various inspired oxygen concentra-
tions. Increase in relaxivity is a measure for oxygen transfer
of inhaled air into the blood stream. OTF describes the inter-
play between oxygen diﬀusion, ventilation, and perfusion.
4. TECHNIQUE
MRT examination of the pulmonary parenchyma exhibits
a minor signal-to-noise ratio. On the one hand, this is due
to minimal lung parenchymal proton density, and on the
other, the multiple air/parenchymal surfaces cause suscepti-
bility jumps which results in an extremely short T2 time of
onlyafewmilliseconds[21–23].Toachievethehighestpossi-
ble signal, a short echo time (TE) is necessary. Therefore, the
use of a single shot turbo spin-echo (TSE) technique has sev-
eral advantages: a short TE, multiple 180◦ refocusing pulses
to minimize susceptibility artifacts, a short inter echo time
to minimize diﬀusion and perfusion eﬀects, and a short ac-
quisition time to reduce motion artifacts. In several studies
[16,17,24,25]aT1weightedinversionrecoveryhalf-Fourier
acquisition single shot turbo spin echo (HASTE) for oxygen
enhanced pulmonary MRT was used.
The calculation of T1 maps allows for the elimination of
T2 eﬀects and the analysis of the eﬀects of oxygen inhala-
t i o n .I nv i v oT 1l u n gm e a s u r e m e n t sa r e ,a sa l lo t h e rM Rp u l -
monary parenchymal measurements, diﬃcult. On the one
side, low-proton densities cause a poor signal-to-noise ratio,
and conversely, measurements are inﬂuenced by susceptibil-
ity artifacts as well as motion artifacts (cardiac pulsation and
diaphragmaticmotion).Mostofthepublishedstudiesexam-
ined an only small volume measurement that naturally cov-
ers only a minor portion of the lung. This results not only
in problems of a statistical nature, but also varying T1 values
are expected where it is then unclear if the entire pulmonary
parenchyma is represented. In order to evaluate diﬀuse, but
regionally inhomogeneous alterations in lung parenchyma,
T1 maps of the entire lung are necessary where there is a cor-
responding T1 value for every pixel.
A possibility which is proposed in several projects, in-
cluding work from our group, calculates T1 maps based on
measurements from snapshot FLASH sequences [10, 26, 27].
These are based on the TOMROP sequence and consist of
two elements: ﬁrst, magnetization is inverted using a nons-
elective inversion pulse, then the return to original magne-
tization state occurs over longitudinal relaxation and an im-
age is created using a series of measurements taken from a
fast snapshot FLASH sequence [28]. The scan time for one
slice at a speciﬁc point in time has an estimated duration of
200 milliseconds and is measured at 16 predeﬁned points in
time after the inversion pulse. Acquisition of an entire slice
lastsaboutfourseconds.Themeasurementprovides16time-
dependantsignalintensitiesforeachpixel.Anexponential-ﬁt
over these data points yields the T1 relaxation time for each
pixel. A color coded image of the T1 values for all the pixels
produces the ﬁnal T1 map (Figure 3).
5. EMPHYSEMA
WHO deﬁnes emphysema as irreversible enlargement of the
air spaces distal to the terminal bronchiole with destruc-
tion of the elastic scaﬀolding without accompanying ﬁbrosis
[29]. The detection and the morphological grading of lung
emphysema using computer tomography have been inten-
sively explored over the last few years [30]. Furthermore,
there are ongoing studies to evaluate the capacity of CT4 International Journal of Biomedical Imaging
(a) (b)
Figure 4 :M o r p h o l o g i c a lC T( a )a n dp e r f u s i o nm a po fa ne m p h y -
sematous lung show good correlation of severe emphysema in the
anterior-lateral parts of the lung and decreased perfusion (green
pixels) as compared to the normal posterior parts of the lung. The
brightredpixelsrepresentexcluded,aircontainingpartsofthelung.
to include functional information like perfusion (Figure 4).
The inherent problems associated with pulmonary MR ex-
aminations, especially the low-proton density (and the poor
signal-to-noise ratio) or the susceptibility artifacts are even
more pronounced in the emphysema altered lung. Indepen-
dent of emphysema pathogenesis, the total composition of
macromolecules such as collagen and elastin are within nor-
mal limits, however the distribution and the organization are
pathologically altered [31]. Signal behavior of the emphy-
semic lung is, apart from a total reduction in signal intensity
which mirrors the pulmonary parenchymal destruction, dif-
ﬁcult to foresee. It was recently demonstrated that the T1 re-
laxation time in emphysematous altered lung is signiﬁcantly
shorterthaninhealthylung(Figure 5)[32].Thecauseofthis
T1 time shortening possibly lies in vascular rarefaction or a
redistribution of blood within the eﬀected lung parenchyma.
In any case, this has to be taken into consideration when per-
forming inhalation examinations. At this time, there is no
deﬁnitive data available relating to T1 relaxation time behav-
ior after 100% oxygen inspiration.
A study from Ohno et al. compared healthy volunteers
with emphysema patients [18], and healthy volunteers with
patients diagnosed with bronchial carcinoma and Bronchial
carcinoma patients without emphysema to those with [25],
respectively. The time course of an acquisition was examined
bytakingsequentialmeasurementsusingHASTEsequencing
with inhalation of 21% (room air) and 100% oxygen.
The 100% oxygen signal rise in patients with pulmonary
emphysema was signiﬁcantly ﬂatter and demonstrated excel-
lent correlation with FEV1. Strong correlation between the
maximum signal rise and CT emphysema scoring as well as
pulmonarydiﬀusioncapacitywasalsonoted.M¨ ullerwasalso
able to show a reduction in diﬀusion capacity in the em-
physemic lung segments when compared to healthy subjects
through dynamic measurements of pulmonary signal behav-





Figure 5: T1 map of a patient with lung emphysema: when com-
pared to a healthy lung (Ill. 1), the T1 time is clearly shortened.
Expiration (b) demonstrates no signiﬁcant prolongation of the T1
time as compared with inspiration (a).
sults, it was demonstrated that inspiration of 100% oxygen
provided a good correlation between the slope of the signal
rise and the clinical measurement of diﬀusion capacity.
The existing studies show that oxygen enhanced pul-
monary MRT can be a valuable complementary tool in eval-
uating pulmonary emphysema patients, especially in spatial
encoded imaging of pulmonary diﬀusion capacity. Investi-
gations in this ﬁeld are, however, still in the preclinical trial
phase.
6. FIBROSIS
Independent of the etiology, pulmonary ﬁbrosis is char-
acterized by the deposition of newly-synthesized matrix
molecules. In accordance with the above described simpli-
ﬁed two compartment model, the relative increase in macro-
molecules should lead to a shortening of the T1 relaxation
time.Thisassumptionwaspartiallyveriﬁedbyanimalmodel
measurements [7], and in some measurements there was no
change in T1 time noted [6]. Our measurements demon-
strated that patients with lung ﬁbrosis, when compared to
healthy volunteer subjects, showed a shortening in the T1





Figure 6: T1 map of a Patient with lung ﬁbroses: in comparison to
a healthy lung (Figure 2), the T1 time is shortened. Expiration (b)
showsasigniﬁcantT1timeprolongationascomparedtoinspiration
(a).
in inspiration (Figure 6)[ 32]. However, there are no current
publications discussing the behavior of the ﬁbrotic lung un-
der 100% oxygen inspiration.
7. CYSTIC FIBROSIS
Cystic ﬁbrosis is an autosomal-recessive hereditary disease
in which the pathological composition of the exocrine gland
secretion leads to characteristic secondary changes in target
organs. In the lungs, this disease has a homogeneous pic-
ture encompassing atelectasis, emphysema, microabscesses,
bronchiectasis which ultimately leads to pulmonary ﬁbrosis.
In a recent work, T1 maps of healthy volunteers were
compared to those of cystic ﬁbrosis patients [20]. The pa-
tient group showed an inhomogeneous distribution of T1
relaxation times where pathologically altered segments had
shorter T1 times than the noneﬀected segments as well as the
lungs of the healthy subjects (Figure 7). The OTF curve of
the pathological lung segments exhibited a distinctly ﬂattend
pattern, consequently, a reduced dependence of pulmonary
parenchymal relaxivity on the inhaled oxygen concentration
(Figure 8). Reasons for this change can either be related to
the limited pulmonary diﬀusion capacity or the alteration
in ventilation or perfusion of the diseased segments, thus




















halation of increasing oxygen concentrations demonstrates a steady
shortening of T1 times in the healthy lung segments. The diseased
tissue of the right mid lobe (arrow) distinguishes itself in that the
T1 time remains relatively unchanged.
8. SUMMARY
T1mapsfromhealthysubjectsandpatientswithemphysema
and ﬁbrosis reveal signiﬁcantly diﬀerent behaviors. These
diﬀerences reﬂect the complex interaction of the structural


























Figure 8: Oxygen transfer function (OTF) of a patient with Cystic
Fibroses from Ill. 6. Healthy lung segments (ROI 2 and 3) demon-
strate a linear increase in relaxivity (=1/T1) with increasing oxy-
gen concentrations. The slope of the curve is a measurement of
lung oxygen transport capacity. The diseased lung segment (ROI
1) shows no rise; there is therefore no oxygen transport.
Pulmonary relaxation mechanisms are still not fully under-
stood. Further studies using T1 maps can advance the un-
derstanding of the relationship between lung structure and
lung function. A basic knowledge of the T1 relaxation mech-
anisms is also the ground work for optimizing conventional
MR pulmonary image sequencing. All published data, up to
now, conﬁrm that oxygen enhanced MRT has an important
role in the imaging of diﬀusion capacity and oxygen trans-
port which provides valuable information in the detection
andunderstandingoftherolethatfunctionalalterationshave
in lung diseases such as emphysema and cystic ﬁbrosis.
In spite of the considerable technical diﬃculties, several
publications conﬁrm the potential that T1 maps and oxy-
gen enhanced MRT have characterizing pathological changes
in lung tissue. However, existing literature still cannot pro-
vide a ﬁnal evaluation of the presented methods. The previ-
ously obtained results will allow for further informative in-
sight into the functional changes of the pathological altered
lung parenchyma.
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